European Pharma Pushes Back Against ‘Discriminatory’ New EU Drug Pollution Proposals
European Commission Insists Its Measures Against Pharmaceutical Pollution Have Wide Support
Medicines for Europe, along with EFPIA and the AESGP, say that the ‘polluter pays’ principle behind proposed new European rules on wastewater treatment would saddle pharmaceutical manufacturers with costs that “jeopardize patient access.”
You may also be interested in...
EU Raises Pressure On Pharmaceutical Pollution Of The Environment
Two EU bodies want to move forward with European Commission proposals on contamination of the environment by pharmaceutical substances.
Gloomy First Half Results For Mayne
Revenue falls 33% over the half year for the ailing Australian pharmaceutical as it pivots from generics to the branded market
Chemiphar Profit Slumps 82.5% In Q3
Plummeting sales and profit following government price regulations pushes Chemiphar to target international expansion